Ci Investments Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 7,140 shares of REGN stock, worth $4.81 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,140

Previous 5,998 19.04%

Holding current value

$4.81 Million

Previous $6.3 Million 19.07%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $1.17 Million - $1.37 Million	1,142 Added 19.04%	7,140 $7.51 Million
Q2 2024 Aug 12, 2024	BUY	$883.2 - $1071.19 $2 Million - $2.42 Million	2,263 Added 60.59%	5,998 $6.3 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $1.2 Million - $1.33 Million	1,334 Added 55.56%	3,735 $3.6 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $220,151 - $250,402	-284 Reduced 10.58%	2,401 $2.11 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $208,427 - $254,155	-301 Reduced 10.08%	2,685 $2.21 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $752,532 - $892,626	1,075 Added 56.25%	2,986 $2.15 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $496,077 - $602,861	729 Added 61.68%	1,911 $1.57 Million
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $153,884 - $167,073	218 Added 22.61%	1,182 $853,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $57,397 - $72,432	100 Added 11.57%	964 $664,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $195,212 - $263,027	-356 Reduced 29.18%	864 $511,000
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $19,638 - $23,048	33 Added 2.78%	1,220 $852,000
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $45,108 - $55,690	83 Added 7.52%	1,187 $750,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $221,575 - $262,850	386 Added 53.76%	1,104 $668,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $10,401 - $12,287	-22 Reduced 2.97%	718 $401,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $19,656 - $24,120	44 Added 6.32%	740 $350,000
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $21,045 - $26,751	-44 Reduced 5.95%	696 $336,000
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $153,619 - $185,615	282 Added 61.57%	740 $414,000
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $225,940 - $294,915	458 New	458 $286,000

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Regeneron Pharmaceuticals, Inc. Transaction History